Retinoblastoma protein expression in ovarian epithelial neoplasms

Gynecol Oncol. 1998 Jun;69(3):214-9. doi: 10.1006/gyno.1998.5015.

Abstract

Progress has been made in identifying the molecular changes that occur in ovarian carcinoma; still our understanding of these changes and their interactions remains incomplete. In the present study the authors examined the expression of retinoblastoma protein, a tumor suppressor protein, in a spectrum of ovarian epithelial tumors including cystadenomas, low-malignant-potential tumors, and carcinomas. A heterogeneous pattern of reactivity was observed in all of the cystadenomas, in all of the low-malignant-potential tumors, and in a majority (27/34) of the carcinomas. The remaining carcinomas showed either a complete absence of reactivity or a pattern of altered reactivity characterized by areas of tumor with intact reactivity adjacent to zones of tumor with a complete absence of reactivity. There was no significant association between grade or stage and absent/altered reactivity. We conclude that alterations of retinoblastoma protein expression are uncommon in ovarian carcinoma.

MeSH terms

  • Carcinoma / chemistry*
  • Carcinoma / genetics
  • Cystadenoma / chemistry*
  • Cystadenoma / genetics
  • Epithelium / chemistry
  • Female
  • Gene Expression
  • Genes, Tumor Suppressor*
  • Humans
  • Immunohistochemistry
  • Ovarian Neoplasms / chemistry*
  • Ovarian Neoplasms / genetics
  • Prognosis
  • Retinoblastoma Protein / analysis*
  • Retinoblastoma Protein / biosynthesis

Substances

  • Retinoblastoma Protein